LNG-IUS or Norethisterone Acetate for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal Women
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Change in endometrial histopathology pattern from endometrial hyperplasia into regression status.
At 3 and 6 months
Hatem Abu Hashim, MD. MRCOG
Mansoura University Hospitals
Egypt: Institutional Review Board